Conversion of warrants
At the first time of conversion of Vitrolife's warrants program 2005/2008,
10,000 warrants have been converted into shares in Vitrolife AB (publ). This
means that at November 30, 2007 the number of shares has increased from
19,790,157 to 19,800,157. The quota value is SEK 1 and the share capital has
thus increased to SEK 19,800,157.
The subscription period for the warrants program 2005/2008 is up until
September 3, 2008. The total number of warrants in the program is 550,000. The
issue price is SEK 30.90.
November 30, 2007
Kungsbacka, Sweden
Vitrolife AB (publ)
Queries should be addressed to:
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.
________________________________________________________________________________
_________
Vitrolife is a global biotechnology/medical device Group that works with
developing, manufacturing and selling advanced products and systems for the
preparation, cultivation and storage of human cells, tissue and organs. The
company has business activities within three product areas: Fertility,
Transplantation and Stem Cell Cultivation. The Fertility product area works with
nutrient solutions (media) and advanced consumable instruments such as needles
and pipettes, for the treatment of human infertility. The Transplantation
product area works with solutions and systems to maintain tissue in optimal
condition outside the body for the required time while waiting for
transplantation. The Stem Cell Cultivation product area works with media and
instruments to enable the use and handling of stem cells for therapeutic
purposes.
Vitrolife today has approximately 140 employees and the company's products
are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and
there are subsidiaries outside Gothenburg, Sweden and in Denver, USA. The
Vitrolife share is listed on the OMX Nordic Exchange's Nordic Small Cap list.
________________________________________________________________________________
_________
Vitrolife AB (publ), Faktorvägen 13, SE-434 37 Kungsbacka, Sweden. Corporate
identity number 556354-3452.
Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com.
Homepage: www.vitrolife.com.
This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
Conversion of warrants
| Source: Vitrolife AB
Attachments
